Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction

Industry Reports

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros.

Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.Ferring is Apricus’ existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners. Apricus will retain its Vitaros rights in the U.S.

"Urology is a key therapeutic area for Ferring," said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. “This agreement strengthens our existing portfolio and reinforces Ferring’s commitment to improving the quality of life of patients with a broad range of urological conditions.”

About Ferring Pharmaceuticals
Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com. 

*Vitaros® is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.  Such trademark is registered in certain countries throughout the world and pending registration in the United States.

For more information:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
This email address is being protected from spambots. You need JavaScript enabled to view it.


Market Movers

Rogers Corporation

NYQ : ROG - 27 Jul, 4:02pm
-2.98 (-2.52%) After Hours:
Open 118.44 Mktcap 2.09B
High 119.09 52wk Hight 119.09
Low 112.29 52wk Low 51.98
Vol 86448 Avg Vol 116548
Eps 5.33 P/e 34.86
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 27 Jul, 4:05pm
-0.02 (-0.30%) After Hours:
Open 6.77 Mktcap 98.12B
High 6.79 52wk Hight 6.99
Low 6.67 52wk Low 3.89
Vol 6.78M Avg Vol 7.57M
Eps 0.49 P/e 13.96
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 27 Jul, 4:00pm
+1.89 (+3.06%) After Hours:
Open 63.67 Mktcap 174.20B
High 64.55 52wk Hight 66.80
Low 62.80 52wk Low 57.18
Vol 21.85M Avg Vol 8.76M
Eps 3.85 P/e 40.59
Currency: USD

Johnson & Johnson

NYQ : JNJ - 27 Jul, 4:01pm
-0.12 (-0.09%) After Hours:
Open 130.85 Mktcap 352.43B
High 131.15 52wk Hight 137.08
Low 129.57 52wk Low 109.32
Vol 5.84M Avg Vol 5.71M
Eps 7.19 P/e 22.14
Currency: USD

Pfizer, Inc.

NYQ : PFE - 27 Jul, 4:00pm
+0.11 (+0.33%) After Hours:
Open 32.79 Mktcap 196.94B
High 33.00 52wk Hight 37.39
Low 32.69 52wk Low 29.83
Vol 16.66M Avg Vol 20.30M
Eps 2.55 P/e 27.78
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 27 Jul, 2:52pm
+0.09 (+0.63%) After Hours:
Open 14.04 Mktcap
High 14.08 52wk Hight 16.29
Low 14.04 52wk Low 12.63
Vol 2820 Avg Vol 5505
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.